Immuno Cure Holding (HK) Limited
2 clinical trials · Sponsor
◉ Watch Immuno Cure Holding (HK) Limited
| Record | Firm | Date |
|---|---|---|
| HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong (NCT07530198) | Immuno Cure Holding (HK) Limited | 2026-03-30 |
| ICVAX as a HIV Therapeutic DNA Vaccine (NCT06253533) | Immuno Cure Holding (HK) Limited | 2023-02-14 |
Track Immuno Cure Holding (HK) Limited automatically
Every clearance here is in the API, with alerts when new ones post.